STOCK TITAN

HOLX CFO files Form 4: RSU grant and tax-withholding entries

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hologic (HOLX) CFO reported equity transactions. On 11/10/2025, she received 43,741 restricted stock units that vest in three equal installments starting November 10, 2025. On 11/07/2025 and 11/11/2025, 9,427 and 1,449 shares were withheld to cover taxes upon PSU/RSU settlement at $74.1 and $74.6, respectively. After these transactions, she beneficially owns 152,068 shares, which includes 41,121 deferred RSUs/PSUs.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Oberton Karleen Marie

(Last) (First) (Middle)
250 CAMPUS DRIVE

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/07/2025 F 9,427(1) D $74.1 109,776(2) D
Common Stock 11/10/2025 A 43,741(3) A (4) 153,517(2) D
Common Stock 11/11/2025 F 1,449(1) D $74.6 152,068(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied.
2. Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
3. Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 10, 2025.
4. Restricted stock units are settled in shares of common stock on a one-for-one basis.
/s/ Mark W. Irving, attorney-in-fact for Ms. Oberton 11/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Hologic (HOLX) disclose in this Form 4?

The CFO reported a grant of 43,741 RSUs on 11/10/2025 and tax-withholding share transactions of 9,427 shares on 11/07/2025 and 1,449 shares on 11/11/2025.

How do the 43,741 RSUs for HOLX’s CFO vest?

They vest in equal installments on each of the first three anniversaries of the grant date, November 10, 2025.

What do the 'F' transaction codes mean in HOLX’s Form 4?

Per the disclosure, they reflect shares withheld to satisfy tax obligations upon settlement of PSUs/RSUs.

What were the prices used for the tax-withholding share entries?

The entries list prices of $74.1 on 11/07/2025 and $74.6 on 11/11/2025.

What is the CFO’s beneficial ownership after these transactions?

She beneficially owns 152,068 shares, including 41,121 deferred RSUs/PSUs.

What is the CFO’s role at Hologic (HOLX)?

She is listed as an Officer, specifically the Chief Financial Officer.
Hologic Inc

NASDAQ:HOLX

HOLX Rankings

HOLX Latest News

HOLX Latest SEC Filings

HOLX Stock Data

16.68B
221.38M
0.86%
101.02%
1.4%
Medical Instruments & Supplies
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
MARLBOROUGH